InsidersTradesSigma
Track the PHARMANUTRA RISULTATI PRIMO SEMESTRE 2023 share price and the full insider trade history of the company, a listed issuer based in Italy. Shares are listed on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA RISULTATI PRIMO SEMESTRE 2023 has published 0 public disclosures. Market capitalisation: €784.2m. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
PHARMANUTRA has released its results for the first half of 2023, showing strong performance in the health and pharmaceutical sector. The company is listed on the XMIL market.